A drug manufacturer is testing a new headache drug. They recruit 100 subjects with headaches and have them rate the severity of their headaches on a scale of 1 to 10. They give them the new drug and one hour later have them again rate the severity of their headaches. They find that 60% of the subjects had substantial reduction in the severity of their headaches. What fundamental component is missing in this experimental design?